In the news:
WuXi AppTec, WuXi Biologics surge in Hong Kong as biotech firms put some operations for sale - Alibaba, JD.com, WuXi Bio lead Hong Kong stock rebound on fund inflows, Fed rate focus - Wuxi AppTec and Wuxi Biologics drop on passage of US bill targeting China biotech firms
WuXi Biologics
Save
ShareKey facts
- city: Wuxi
- country: China
- sector: Health Care
- industry: Biotechnology
- CEO: Dr. Zhisheng Chen
Classified as: organization
Summary
WuXi Biologics is a company. It is located in Wuxi, China. The company is part of the Health Care sector, specifically in the Biotechnology industry.
Business
WuXi Biologics is one of the companies in China, companies in Biotechnology, companies in Health Care and 3,466,499 companies in our database.
- Assets: 6.4B $
- Debt: 620.6M $
- Employees: 9,864 people
- Free cash flow: -537554000 $
- Market cap: 35.8B $
- Profits: 489.6M $
- Revenues: 1.5B $
Stocks from WuXi Biologics
Explore more on business
Talking Points:
- A leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing
- WuXi Biologics, a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions.
- A true global single-source drug development technology platform from concept to commercialization. | Our Vision: "Every drug can be made and every disease can be treated" by building an open-access platform with the most comprehensive capabilities and technologies in the global biologics industry. Our Mission: To accelerate and transform the ...
- WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.
Learn more about talking points